States sue over Part D Rx costs
At least five states will appeal directly to the U.S. Supreme Court to block the federal government from billing them for millions of dollars for drugs for former Medicaid patients switched to Medicare Part D plans. Although Congress had assured states that the change would lower their drug costs by 10%, the states contend that a flaw in the financial formula is leading the federal government to overcharge them.
Recent Videos
Related Content
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Podcast
Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.
